Signature Wealth Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.26M | Buy |
24,181
+147
| +0.6% | +$32.6K | 2% | 16 |
|
|
2025
Q4 | $5.49M | Sell |
24,034
-1,210
| -5% | -$276K | 2.24% | 9 |
|
|
2025
Q3 | $5.85M | Buy |
25,244
+235
| +0.9% | +$47.9K | 2.27% | 6 |
|
|
2025
Q2 | $4.64M | Buy |
25,009
+230
| +0.9% | +$42.7K | 1.83% | 13 |
|
|
2025
Q1 | $5.19M | Sell |
24,779
-673
| -3% | -$131K | 2.02% | 9 |
|
|
2024
Q4 | $4.52M | Buy |
25,452
+505
| +2% | +$92.8K | 1.82% | 14 |
|
|
2024
Q3 | $4.93M | Sell |
24,947
-1,519
| -6% | -$283K | 1.98% | 11 |
|
|
2024
Q2 | $4.54M | Sell |
26,466
-784
| -3% | -$130K | 1.99% | 12 |
|
|
2024
Q1 | $4.53M | Sell |
27,250
-1,175
| -4% | -$203K | 2.06% | 11 |
|
|
2023
Q4 | $4.4M | Buy |
+28,425
| New | +$4.14M | 2.04% | 11 |
|
|
2023
Q2 | $3.9M | Buy |
28,961
+485
| +2% | +$71.1K | 1.82% | 18 |
|
|
2023
Q1 | $4.54M | Sell |
28,476
-333
| -1% | -$50.9K | 2.15% | 10 |
|
|
2022
Q4 | $4.66M | Sell |
28,809
-955
| -3% | -$146K | 2.28% | 9 |
|
|
2022
Q3 | $4M | Sell |
29,764
-1,956
| -6% | -$281K | 2.03% | 9 |
|
|
2022
Q2 | $4.86M | Sell |
31,720
-3,707
| -10% | -$566K | 2.36% | 4 |
|
|
2022
Q1 | $5.74M | Sell |
35,427
-605
| -2% | -$87.9K | 2.59% | 3 |
|
|
2021
Q4 | $4.88M | Sell |
36,032
-841
| -2% | -$99.3K | 2.46% | 4 |
|
|
2021
Q3 | $3.98M | Sell |
36,873
-291
| -0.8% | -$33.3K | 2.21% | 6 |
|
|
2021
Q2 | $4.19M | Sell |
37,164
-169
| -0.5% | -$19K | 2.33% | 4 |
|
|
2021
Q1 | $4.04M | Sell |
37,333
-304
| -0.8% | -$32.5K | 2.38% | 5 |
|
|
2020
Q4 | $4.03M | Buy |
37,637
+997
| +3% | +$95.8K | 2.54% | 4 |
|
|
2020
Q3 | $3.21M | Buy |
36,640
+3
| +0% | +$282 | 2.31% | 11 |
|
|
2020
Q2 | $3.6M | Sell |
36,637
-133
| -0.4% | -$11.7K | 2.75% | 4 |
|
|
2020
Q1 | $2.8M | Sell |
36,770
-58
| -0.2% | -$4.94K | 2.46% | 13 |
|
|
2019
Q4 | $3.26M | Buy |
36,828
+843
| +2% | +$70K | 2.06% | 19 |
|
|
2019
Q3 | $2.73M | Sell |
35,985
-5
| -0% | -$343 | 1.8% | 34 |
|
|
2019
Q2 | $2.63M | Buy |
35,990
+738
| +2% | +$58K | 1.75% | 36 |
|
|
2019
Q1 | $2.84M | Buy |
35,252
+3,132
| +10% | +$256K | 1.99% | 28 |
|
|
2018
Q4 | $2.96M | Buy |
32,120
+521
| +2% | +$45.8K | 2.3% | 17 |
|
|
2018
Q3 | $2.57M | Buy |
31,599
+1,795
| +6% | +$170K | 1.91% | 25 |
|
|
2018
Q2 | $2.76M | Buy |
29,804
+503
| +2% | +$49.1K | 2.04% | 23 |
|
|
2018
Q1 | $2.77M | Sell |
29,301
-13,297
| -31% | -$1.46M | 2.14% | 21 |
|
|
2017
Q4 | $4.12M | Buy |
+42,598
| New | +$4.01M | 3.02% | 3 |
|
Other funds holding ABBV
Signature Wealth Management Group's ABBV Position: Q1 2026 in Review
Signature Wealth Management Group increased its AbbVie (ABBV) stake by 0.61% in Q1 2026, buying an estimated $32.6K and bringing the position to 24,181 shares worth $5.26M. The position accounts for 2% of the portfolio, ranked #16.
Signature Wealth Management Group first reported a position in ABBV in Q4 2017 and has held it in 33 quarters since. The position peaked at $5.85M in Q3 2025. 4,103 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Signature Wealth Management Group held 24,181 shares of AbbVie worth $5.26M as of Q1 2026.
- Signature Wealth Management Group bought 147 AbbVie shares in Q1 2026, an estimated $32.6K.
- AbbVie made up 2% of Signature Wealth Management Group's portfolio in Q1 2026, its #16 holding.
- Signature Wealth Management Group first reported a position in AbbVie in Q4 2017 and has held it in 33 quarters since.
- Signature Wealth Management Group's AbbVie position peaked at $5.85M in Q3 2025.
- 4,103 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Signature Wealth Management Group's 13F filing for Q1 2026, filed 1 Apr 2026.